* Investment Date & Round, Led Seed round in 2012 (Invested $110K)
* Initial Premoney Valuation ~3M (Est. Value ~$5M)
* Acquisition: Rapid growth; paper submission; Up 300% per quarter. Breakeven and no capital required
* Exit Valuation: Uncertain
* Return Multiple: TBD

Cureus is an online medical publishing platform that allows papers to be published in 1-2 days. It uses a social media approach to rate the quality of the papers, and it is accessible to the general public. The platform runs an advertising model to generate revenue. The current medical publishing process requires months for peer-review, and  the subscription cost for the journal can be over $1000. Medicine’s advancement is retarded by the old publishing process.

Cureus was founded by Dr. John Adler, a famous neurosurgeon, founder of Accuray, and faculty member at the Stanford Medical School. Dr. Adler had been dealing with the long delays in our archaic publishing system for decades. After his son founded Scribd, he realized that medicine needed this same publishing platform very  badly. The platform is now growing rapidly as doctors are realizing that social media can be applied to medicine to speed up change.
​
Ted Driscoll remains an Advisor to this company.